Inventor · disambiguated record
Ravishanker Kovi
Also filed as: KOVI RAVISHANKER
31 granted patents·30 pending applications·32 citations·filing 2006–2023
94Inventor score
Top patents by PatentIndex Score
61 records- 0195US8969616B2Process for preparation of isosulfan blueKOVI RAVISHANKER·Filed 2013·Granted Mar 3, 2015·11 cites·23 claims
- 0294US9353050B2Process for preparation of isosulfan blueKOVI RAVISHANKER·Filed 2011·Granted May 31, 2016·7 cites·18 claims
- 0392US7662992B2Process for preparation of isosulfan blueAPICORE LLC·Filed 2008·Granted Feb 16, 2010·10 cites·23 claims
- 0481US10626086B2Process for the preparation of isosulfan blueAPICORE US LLC·Filed 2019·Granted Apr 21, 2020·0 cites·13 claims
- 0580US10508080B2Process for the preparation of isosulfan blueAPICORE US LLC·Filed 2019·Granted Dec 17, 2019·0 cites·18 claims
- 0680US10464888B2Process for the preparation of isosulfan blueAPICORE US LLC·Filed 2019·Granted Nov 5, 2019·0 cites·22 claims
- 0779US10590071B2Process for the preparation of isosulfan blueAPICORE US LLC·Filed 2018·Granted Mar 17, 2020·0 cites·21 claims
- 0879US9493473B2Processes for making ponatinib and intermediates thereofAPICORE US LLC·Filed 2015·Granted Nov 15, 2016·2 cites·8 claims
- 0976US2020347013A1Process for preparation of isosulfan blueAPICORE US LLC·Filed 2020·Application pending·0 cites
- 1075US10752580B2Process for preparation of isosulfan blueAPICORE US LLC·Filed 2017·Granted Aug 25, 2020·0 cites·13 claims
- 1173US10221184B2Polymorphs of ponatinib hydrochlorideAPICORE US LLC·Filed 2018·Granted Mar 5, 2019·1 cites·12 claims
- 1270US11260065B2Storage-stable ready-to-use injectable formulations of thiotepaRK Pharma Solutions LLC·Filed 2019·Granted Mar 1, 2022·1 cites·20 claims
- 1370US2016221936A1Process for preparation of isosulfan blueAPICORE US LLC·Filed 2016·Application pending·0 cites
- 1467US2010094044A1Process for preparation of isosulfan blueAPICORE LLC·Filed 2009·Application pending·0 cites
- 1562US11034714B2Process of making regadenoson and novel polymorphs thereofAPICORE US LLC·Filed 2019·Granted Jun 15, 2021·0 cites·10 claims
- 1661US2008281127A1Process for preparation of isosulfan blueAPICORE LLC·Filed 2007·Application pending·0 cites
- 1760US2021361644A1Storage-stable ready-to-use injectable formulations of trabectedinRK Pharma Solutions LLC·Filed 2021·Application pending·0 cites
- 1858US9150511B2Process for preparing saxagliptin and its novel intermediates useful in the synthesis thereofAPICORE US LLC·Filed 2014·Granted Oct 6, 2015·0 cites·2 claims
- 1957US2021169873A1Storage-stable ready-to-use injectable formulations of TrabectedinRK Pharma Solutions LLC·Filed 2020·Application pending·0 cites
- 2056US10442813B2Polymorphs of rucaparib camsylate and methods of making sameRK Pharma Solutions LLC·Filed 2019·Granted Oct 15, 2019·0 cites·16 claims
- 2156US2014343282A1Processes for making ponatinib and intermediates thereofAPICORE LLC·Filed 2014·Application pending·0 cites
- 2255US11654151B2Storage-stable ready-to-use formulations of tigecyclineRK Pharma Solutions LLC·Filed 2020·Granted May 23, 2023·0 cites·3 claims
- 2354US11447513B2Purification process of ferric carboxymaltoseRK Pharma Solutions LLC·Filed 2021·Granted Sep 20, 2022·0 cites·8 claims
- 2454US2024270694A1Process for the preparation of ivacaftor and novel solvates thereofRK PHARMA INC·Filed 2023·Application pending·0 cites
- 2554US2017008848A1Methods of making netupitant and intermediates thereofAPICORE US LLC·Filed 2016·Application pending·0 cites
- 2654US2024010644A1Process for the preparation of isavuconazonium sulfateRK PHARMA INC·Filed 2023·Application pending·0 cites
- 2753US12396999B2Composition of ferric maltol for oral administrationRK PHARMA INC·Filed 2022·Granted Aug 26, 2025·0 cites·2 claims
- 2853US7446227B2Process for preparation of 5H-dibenzo[a,d] cycloheptene derivativesAPICORE LLC·Filed 2006·Granted Nov 4, 2008·0 cites·7 claims
- 2952US11857677B2Ready to use injectable formulations of melphalan and processes for preparation thereofRK Pharma Solutions LLC·Filed 2020·Granted Jan 2, 2024·0 cites·1 claims
- 3052US2008242892A1PROCESS FOR PREPARATION OF 5H DIBENZO[a,d] CYCLOHEPTENE DERIVATIVESAPICORE LLC·Filed 2008·Application pending·0 cites
- 3151US11447499B2Process for the preparation of eribulin mesylate intermediateRK Pharma Solutions LLC·Filed 2020·Granted Sep 20, 2022·0 cites·1 claims
- 3251US10442832B2Process of making regadenoson and novel polymorph thereofAPICORE US LLC·Filed 2016·Granted Oct 15, 2019·0 cites·9 claims
- 3351US8748631B2Process for preparing saxagliptin and its novel intermediates useful in the synthesis thereofKOVI RAVISHANKER·Filed 2012·Granted Jun 10, 2014·0 cites·1 claims
- 3451US2021139518A1Novel polymorphic form of ferric maltolRK Pharma Solutions LLC·Filed 2020·Application pending·0 cites
- 3551US2025145580A1An improved process for the preparation of ferric maltolRK PHARMA INC·Filed 2022·Application pending·0 cites
- 3651US2015315149A1Methods of making netupitant and intermediates thereofAPICORE US LLC·Filed 2015·Application pending·0 cites
- 3750US10519121B2Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable saltsAPICORE US LLC·Filed 2017·Granted Dec 31, 2019·0 cites·4 claims
- 3850US2022040092A1Ready to use injectable formulations of Micafungin SodiumRK Pharma Solutions LLC·Filed 2021·Application pending·0 cites
- 3949US9822145B2Methods of making carfilzomib and intermediates thereofAPICORE US LLC·Filed 2016·Granted Nov 21, 2017·0 cites·15 claims
- 4048US2014336369A1Process for preparing heparinoids and intermediates useful in the synthesis thereofAPICORE US LLC·Filed 2014·Application pending·0 cites
- 4147US12215234B2Process for the purification of methylene blueRK Pharma Solutions LLC·Filed 2020·Granted Feb 4, 2025·0 cites·2 claims
- 4247US9988389B2Processes for making ponatinib and intermediates thereofAPICORE US LLC·Filed 2016·Granted Jun 5, 2018·0 cites·7 claims
- 4347US2018360917A1Sincalide formulations and methods of useAPICORE LLC·Filed 2018·Application pending·0 cites
- 4447US2016368875A1Methods of making netupitant and intermediates thereofAPICORE US LLC·Filed 2016·Application pending·0 cites
- 4547US2018037606A1Methods of making carfilzomib and intermediates thereofAPICORE US LLC·Filed 2017·Application pending·0 cites
- 4646US10392417B2Polymorph of regadenoson and process for preparation thereofAPICORE US LLC·Filed 2017·Granted Aug 27, 2019·0 cites·4 claims
- 4746US2018044345A1Processes for making ponatinib and intermediates thereofAPICORE US LLC·Filed 2017·Application pending·0 cites
- 4845US2013237707A1Cis-2-methylspiro 1, 3-oxathiolane 5-3 quinuclidineAPICORE LLC·Filed 2013·Application pending·0 cites
- 4944US11324771B2Process for the preparation of hydroxocobalamin hydrochlorideRK Pharma Solutions LLC·Filed 2020·Granted May 10, 2022·0 cites·6 claims
- 5044US8450487B2Process for the preparation of cis-2-methylspiro (1,3-oxathiolane 5-3′) quinuclidineKOVI RAVISHANKER·Filed 2010·Granted May 28, 2013·0 cites·15 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ravishanker Kovi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →